Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)
Phase of Trial: Phase III
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Edoxaban (Primary) ; Warfarin
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms ENAVLE Trial
- 08 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jul 2019.
- 19 Jun 2018 Status changed from not yet recruiting to recruiting.
- 13 Oct 2017 Planned initiation date changed from 1 Aug 2017 to 1 Dec 2017.